date,title,source
Oct-22-18,ContraFect to Participate in World Antimicrobial Resistance Congress 2018,GlobeNewswire
Nov-01-18,ContraFect to Present at 2nd International Symposium on Antimicrobial Hydrolytic Enzymes,GlobeNewswire
Nov-08-18,ContraFect: 3Q Earnings Snapshot,Associated Press
Nov-08-18,ContraFect Announces Third Quarter 2018 Financial Results,GlobeNewswire
Nov-12-18,CFRX: Waiting on Data from Phase 2 Study of CF-301,Zacks Small Cap Research
Nov-12-18,ContraFect Appoints Michael Messinger as Chief Financial Officer,GlobeNewswire
Nov-16-18,"Investor Expectations to Drive Momentum within 2U, Broadwind Energy, Nuverra Environmental Solutions, Ability, ContraFect, and Conatus Pharmaceuticals  Discovering Underlying Factors of Influence",GlobeNewswire
Nov-19-18,ContraFect to Present at Piper Jaffray Health Care Conference,GlobeNewswire
Dec-20-18,ContraFect to Present at Biotech Showcase 2019,GlobeNewswire
Jan-09-19,CFRX: Exebacase Improves Clinical Outcomes in Phase 2 Trial,Zacks Small Cap Research
